Delhi, June 17: The Serum Institute of India (SII) is expected to begin clinical trials of the Novavax vaccine for children in July 2021. This will be the fourth Covid-19 vaccine to undergo a clinical trial for children.
Hyderabad-based Bharat Biotech has already started clinical trials of Covaxin for children aged 12 to 18 years of age. A total of 525 children are part of these trials being conducted at the All India Institute of Medical Sciences (AIIMS) in New Delhi and Patna.
Clinical trials for Covaxin will also be conducted for children in the 6-12 age group followed by the 2-6 age group.
Vaccine maker Bharat Biotech is also conducting clinical trials testing its nasal Covid-19 vaccine for children.
Zydus Cadila has also begun the trials of its Covid-19 vaccine, ZyCoV-D, in children aged 12-18. The pharma company now plans to conduct clinical trials for its vaccine in children in the 5-12 age group.